Tissue Engineered – Skin Substitutes Market Size by Segments, Share, Regulatory, Reimbursement and Forecast to 2033
Powered by
All the vital news, analysis, and commentary curated by our industry experts.
Tissue Engineered Skin Substitutes Market Report Overview
The tissue engineered skin substitutes market size is $2.2 billion in 2023. The market is expected to grow at a CAGR of more than 3% during 2023-2033. Tissue engineering for wound care management refers to the mechanical and chemical processing of materials to manufacture products that may substitute or replace all or some components that make up normal skin.
Tissue Engineered Skin Substitutes Market Outlook, 2023-2033 ($ Billion)
Buy the Full Report for More Insights into the Tissue Engineered Skin Substitutes Market Forecast
The tissue engineered skin substitutes market research report is built to visualize quantitative market trends within the Wound Care Management therapeutic area. The model discusses in detail the impact of COVID-19 on the tissue engineered skin substitutes market for the year 2020 and beyond. Each of the covered 39 countries’ color-coded and fully sourced market model is equipped with epidemiology-based indications with procedure volumes.
Market Size (2023) | $2.2 billion |
CAGR (2023-2033) | >3% |
Forecast Period | 2023-2033 |
Historical Period | 2015-2022 |
Key Segments | · Acellular Skin Substitutes
· Cellular Skin Substitutes |
Key Regions | · North America
· Europe · Asia Pacific · South Central America · Middle East and Africa |
Leading Companies | · Integra LifeSciences Corp
· LifeNet Health Inc · MiMedx Group Inc · Organogenesis Holdings Inc · Smith & Nephew Plc · Allergan Ltd |
Enquire & Decide | Discover the perfect solution for your business needs. Enquire now and let us help you make an informed decision before making a purchase. |
Tissue Engineered Skin Substitutes Market Dynamics
The rapidly growing & urbanizing global population is set to impact the tissue engineered skin substitutes market significantly. The market is poised to witness significant growth owing to a rise in healthcare infrastructure with technologically advanced practices and higher spending in developing countries. Additionally, a rise in the prevalence of burn injuries, other skin diseases, and growing incidences of chronic and burn wounds coupled with a rising geriatric population drive the tissue engineered skin substitutes market.
Tissue Engineered Skin Substitutes Market Segments
The tissue engineered skin substitutes market can be segmented into acellular skin substitutes and cellular skin substitutes. Acellular skin substitutes lead the tissue engineered skin substitutes market in 2023. Acellular biomaterials can stimulate the micro-environment to heal wounds without the regulatory and scientific challenges of cellular treatment. Acellular skin substitutes can be further sub-segmented into acellular skin substitutes based on amniotic membrane and other acellular skin substitutes. The other acellular skin substitutes have higher market value in 2023.
Tissue Engineered Skin Substitutes Market Analysis by Segments, 2023 (%)
Buy the Full Report to Know More about the Segments in the Tissue Engineered Skin Substitutes Market
Tissue Engineered Skin Substitutes Market Segmentation by Regions
The key regions in the tissue engineered skin substitutes market are North America, Europe, the Asia-Pacific, South Central America, and the Middle East & Africa. North America dominates the market in 2023. The region has a well-developed healthcare sector and high per capita healthcare expenditures. TESS technology is especially inclined toward the elderly population for whom easily accessible healthcare is paramount. Moreover, the increasing geriatric population and developed economies of the US and Canada further fuel market growth within the region. The North American population desires more efficient solutions for their illnesses, which is an additional factor driving market growth.
Tissue Engineered Skin Substitutes Market Analysis by Regions, 2023 (%)
Buy the Full Report to Know More about the Regions in the Tissue Engineered Skin Substitutes Market
Tissue Engineered Skin Substitutes Market - Competitive Landscape
Some of the leading companies in the tissue engineered skin substitutes market are Integra LifeSciences Corp, LifeNet Health Inc, MiMedx Group Inc, Organogenesis Holdings Inc, Smith & Nephew Plc, and Allergan Ltd. Allergan Ltd. holds the largest share of the tissue engineered skin substitutes market in 2023.
Tissue Engineered Skin Substitutes Market Analysis by Companies, 2023 (%)
Buy the Full Report to Know More about the Companies in the Tissue Engineered Skin Substitutes Market
Segments Covered in the Report
Tissue Engineered Skin Substitutes Segment Outlook (Value, $ Billion, 2015-2033)
- Acellular Skin Substitutes
- Acellular Skin Substitutes Based on Amniotic Membrane
- Other Acellular Skin Substitutes
- Cellular Skin Substitutes
- Cellular Skin Substitutes Based on Amniotic Membrane
- Other Cellular Skin Substitutes
Tissue Engineered Skin Substitutes Regional Outlook (Value, $ Billion, 2015-2033)
- North America
- Europe
- Asia Pacific
- South Central America
- Middle East and Africa
Key Inclusions
Key Inclusions of the market model are:
Currently marketed tissue engineered skin substitutes and evolving competitive landscape –
– Insightful review of the key industry trends.
– Annualized total Tissue Engineered Skin Substitutes market revenue by segment and market outlooks from 2015-2033.
– Granular data on total procedures, units, average selling prices, and market values by segment.
Global, Regional, and Country level market specific insights –
– Qualitative market-specific information is available with global trends further broken down into regional trends. In addition, GlobalData analysts provide unique country-specific insights on the market.
– SWOT analysis for the tissue engineered skin substitutes market.
– Competitive dynamics insights and trends provided for the tissue engineered skin substitutes market.
Drive the understanding of the market by getting the veritable big picture including an overview of the healthcare system. In addition, the market access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape.
– Country-specific overview of the healthcare system.
– Country-specific reimbursement policies.
– Country-specific medtech regulatory landscape.
Robust methodologies and sources enable the model to provide an extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, real-world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.
Companies covered – Integra LifeSciences Corp, LifeNet Health Inc, MiMedx Group Inc, Organogenesis Holdings Inc, Smith & Nephew Plc, Allergan Ltd, and others.
Countries covered – United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina, and Chile.
Scope
This Market Model gives important, expert insight you won’t find in any other source. The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for:
- CMO executives who must have a deep understanding of the Tissue Engineered Skin Substitutes marketplace to make strategic planning and investment decisions.
- Sourcing and procurement executives who must understand crucial components of the supply base to make decisions about supplier selection and management.
- Private equity investors who need a deeper understanding of the market to identify and value potential investment targets.
Reasons to Buy
The model will enable you to –
- Understand the impact of COVID-19 on Tissue Engineered Skin Substitutes market.
- Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline.
- Develop business strategies by understanding the trends shaping and driving the Tissue Engineered Skin Substitutes market.
- Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the Tissue Engineered Skin Substitutes market in the future.
- Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the company share of market leaders.
- Identify emerging players with potentially strong product portfolios and create effective counterstrategies to gain a competitive advantage.
- Track device sales in the global and country-specific Tissue Engineered Skin Substitutes market from 2015-2033.
- Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments, and strategic partnerships.
LifeNet Health Inc
MiMedx Group Inc
Organogenesis Holdings Inc
Smith & Nephew Plc
Allergan Ltd
Others
Frequently asked questions
-
What is the tissue engineered skin substitutes market size in 2023?
The tissue engineered skin substitutes market size is $2.2 billion in 2023.
-
What is the growth rate of the tissue engineered skin substitutes market?
The tissue engineered skin substitutes market is expected to grow at a CAGR of more than 3% during 2023-2033.
-
Which is the leading segment of the tissue engineered skin substitutes market in 2023?
Acellular skin substitutes lead the tissue engineered skin substitutes market in 2023.
-
Which region holds the largest share of the tissue engineered skin substitutes market?
North America holds the largest tissue engineered skin substitutes market share in 2023.
-
Who are the major players operating in the tissue engineered skin substitutes market?
Some of the leading companies in the tissue engineered skin substitutes market are Integra LifeSciences Corp, LifeNet Health Inc, MiMedx Group Inc, Organogenesis Holdings Inc, Smith & Nephew Plc, and Allergan Ltd.
Get in touch to find out about multi-purchase discounts
reportstore@globaldata.com
Tel +44 20 7947 2745
Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.